If detected early, the prognosis for skin cancer is excellent. An innovative full-body scanner linked to an AI diagnostic platform is set to help with early detection of melanoma. In just six minutes, it automatically scans a patient’s entire body, providing a risk assessment for each anomalous change found in the skin.
Of Interest
1 in 5 Patients Experience Skin Toxicity With Nivolumab/Relatlimab
In a study of patients with advanced melanoma, the prevalence of cutaneous immune–related adverse events (cirAEs) associated with nivolumab/relatlimab combination therapy was 21.5%, with rash and maculopapular eruption being most common.
Handheld Reflectance Confocal Microscopy Efficacious for Detecting Lentigo Maligna (Melanoma)
WEDNESDAY, March 5, 2025 (HealthDay News) — Handheld reflectance confocal microscopy (HH-RCM) is promising for detecting subclinical lentigo maligna (melanoma; LM/LMM), according to a study published in the March issue of the Journal of the European Academy of Dermatology & Venereology.
Dermatologists must be ‘actively involved’ in AI development to reduce disparities
ORLANDO — AI can transform how dermatologists diagnose skin conditions including melanoma; however, without attention to equitability, specifically in skin of color, it could exacerbate disparities in care, according to a speaker here.